About Leukocare
Leukocare is a company based in Munchen (Germany) founded in 2003. Leukocare has raised $17.5 million across 2 funding rounds from investors including Petrichor and LifeCare Partners. The company has 70 employees as of December 31, 2021. Leukocare offers products and services including Formulation Development, Data Science Services, Stability Studies, and Particle Characterization. Leukocare operates in a competitive market with competitors including Jubilant Life Sciences, Recipharm, Akums, Unither and Nectar Lifesciences, among others.
- Headquarter Munchen, Germany
- Employees 70 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Leukocare Ag
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$17.5 M (USD)
in 2 rounds
-
Latest Funding Round
$17.5 M (USD), Series B
Jun 23, 2021
-
Investors
Petrichor
& 1 more
-
Employee Count
70
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Leukocare
Leukocare offers a comprehensive portfolio of products and services, including Formulation Development, Data Science Services, Stability Studies, and Particle Characterization.
Optimizes formulations for biopharmaceuticals to enhance stability and efficacy.
Applies AI and bioinformatics for drug development and risk reduction.
Evaluates drug product stability under various conditions for safety.
Analyzes particles in drug substances to ensure quality and manufacturability.
People of Leukocare
Unlock access to complete
Unlock access to complete
Funding Insights of Leukocare
Leukocare has successfully raised a total of $17.5M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $17.5 million completed in June 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Leukocare
Leukocare has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Petrichor and LifeCare Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Petrichor is engaged in supporting healthcare innovation through investments.
|
Locked | Locked | Locked | |
|
LifeCare Partners is involved in unspecified activities.
|
Locked | Locked | Locked |
Investor details for Leukocare
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Leukocare
Investment portfolio details for Leukocare
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Leukocare
Detailed financials for Leukocare
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Leukocare Comparisons
Peer comparison for Leukocare
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Leukocare
Leukocare operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jubilant Life Sciences, Recipharm, Akums, Unither and Nectar Lifesciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| Locked | Locked | Locked |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| Locked | Locked | Locked |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| Locked | Locked | Locked |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| Locked | Locked | Locked |
Cephalosporin APIs and generic formulations are manufactured.
|
|
| Locked | Locked | Locked |
CDMO with a focus on early phase drug product development
|
Detailed competitors of Leukocare
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Leukocare
Complete news archive for Leukocare
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Leukocare
Leukocare was founded in 2003 and raised its 1st funding round 12 years after it was founded.
Leukocare is headquartered in Munchen, Germany. It is registered at Munchen, Bayern, Germany.
Leukocare is a funded company, having raised a total of $17.5M across 2 funding rounds to date.
As of Dec 31, 2021, the latest employee count at Leukocare is 70.
Leukocare offers a proprietary formulation platform for the development of biologics. Their proprietary Stabilising and Protecting Solutions (SPS) platform offers technologies for increasing the stability and protection of therapeutic proteins in dry and liquid formulations. The platform mainly includes three major functionalities namely thermal stabilization, sterilization protection (for terminal sterilization and dry formulation of biologics) and device functionalization (for medical devices). The platform can be used mainly for the development of therapeutic antibodies, biosimilars, vaccines and medical devices. The company recently entered into a strategic alliance with Rentschler Biotechnologie, a Germany-based CDMO through which Leukocare would become its specialized technology partner and exclusive formulation developer.
Leukocare's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Leukocare offers Formulation Development, Data Science Services, Stability Studies, and Particle Characterization.
Leukocare has 2 investors. Key investors include Petrichor, and LifeCare Partners.